Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T. Sakamoto S, et al. Clin Lung Cancer. 2017 Nov;18(6):e385-e394. doi: 10.1016/j.cllc.2017.03.011. Epub 2017 Mar 24. Clin Lung Cancer. 2017. PMID: 28416261 Free article. Clinical Trial.
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma.
Tokumo K, Masuda T, Miyama T, Miura S, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Miyamoto S, Yoshida T, Iwamoto H, Fujitaka K, Hamada H, Hattori N. Tokumo K, et al. Among authors: sakamoto s. Lung Cancer. 2018 May;119:21-24. doi: 10.1016/j.lungcan.2018.02.018. Epub 2018 Mar 2. Lung Cancer. 2018. PMID: 29656748
Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study.
Yamaguchi K, Masuda T, Fujitaka K, Miwata K, Sakamoto S, Horimasu Y, Hamai K, Miyamoto S, Nakashima T, Okamoto Y, Iwamoto H, Ishikawa N, Miyata Y, Okada M, Hamada H, Hattori N. Yamaguchi K, et al. Among authors: sakamoto s. In Vivo. 2018 Sep-Oct;32(5):1155-1160. doi: 10.21873/invivo.11358. In Vivo. 2018. PMID: 30150438 Free PMC article. Clinical Trial.
Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study.
Masuda T, Watanabe M, Fujitaka K, Hamai K, Ishikawa N, Doi M, Kitaguchi S, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Nakashima T, Senoo T, Iwamoto H, Hamada H, Hattori N. Masuda T, et al. Among authors: sakamoto s. Mol Clin Oncol. 2018 Nov;9(5):539-544. doi: 10.3892/mco.2018.1705. Epub 2018 Aug 24. Mol Clin Oncol. 2018. PMID: 30345049 Free PMC article.
3,405 results